Advertisement

Early-Onset Sepsis

  • Susan A. Lee
Chapter

Abstract

Early-onset sepsis (EOS) remains a major cause of neonatal morbidity and mortality. Even in the era of universal group B Streptococcus (GBS) screening and intrapartum antibiotic prophylaxis, EOS due to GBS and gram-negatives such as Escherichia coli is common. Both maternal and neonatal risk factors can be used to guide decisions regarding diagnostic evaluations and empiric antibiotic therapy for EOS. Prevention can be optimized by providing adequate prenatal care, reducing preterm deliveries, and providing intrapartum antibiotic prophylaxis when warranted.

Keywords

Group B Streptococcus Escherichia coli Neonate Prematurity Sepsis 

References

  1. 1.
    Shane AL, Sanchez PJ, Stoll BJ. Neonatal sepsis. Lancet. 2017;390:1770–80.CrossRefPubMedGoogle Scholar
  2. 2.
    Schrag SJ, Farley MM, Petit S, et al. Epidemiology of invasive early-onset neonatal sepsis, 2005 to 2014. Pediatrics. 2016;138:e20162013.CrossRefPubMedGoogle Scholar
  3. 3.
    Stoll BJ, Hansen NI, Sanchez PJ, et al. Early onset neonatal sepsis: the burden of group B streptococcal and E coli disease continues. Pediatrics. 2011;127:817–26.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Higgins RD, Saade G, Polin RA, et al. Evaluation and management of women and newborns with a maternal diagnosis of chorioamnionitis: summary of a workshop. Obstet Gynecol. 2016;127:426–36.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Wortham JM, Hansen NI, Schrag SJ, et al. Chorioamnionitis and culture-confirmed, early-onset neonatal infections. Pediatrics. 2016;137:e20152323.CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Kuzniewicz MW, Puopolo KM, Fischer A, et al. A quantitative, risk-based approach to the management of neonatal early-onset sepsis. JAMA Pediatr. 2017;171:365–71.CrossRefPubMedGoogle Scholar
  7. 7.
    Weintraub AS, Cadet CT, Perez R, et al. Antibiotic use in newborns with transient tachypnea of the newborn. Neonatology. 2013;103:235–40.CrossRefPubMedGoogle Scholar
  8. 8.
    Shani L, Weitzman D, Melamed R, et al. Risk factors for early sepsis in very low birth weight neonates with respiratory distress syndrome. Acta Paediatr. 2008;97:12–5.CrossRefPubMedGoogle Scholar
  9. 9.
    Dempsey EM, Barrington KJ. Diagnostic criteria and therapeutic interventions for the hypotensive very low birth weight infant. J Perinatol. 2006;26:677–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Polin RA. Committee on fetus and newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012;129:1006–15.CrossRefGoogle Scholar
  11. 11.
    Cantey JB, Baird SD. Ending the culture of culture-negative sepsis in the neonatal ICU. Pediatrics. 2017;140:e2017044.CrossRefGoogle Scholar
  12. 12.
    Lu Q, Zhou M, Tu Y, Yao Y, Yu J, Cheng S. Pathogen and antimicrobial resistance profiles of culture-proven neonatal sepsis in Southwest China, 1990-2014. J Paediatr Child Health. 2016;52:939–43.CrossRefPubMedGoogle Scholar
  13. 13.
    Bizzaro MJ, Dembry LM, Baltimore RS, Gallagher PG. Changing patterns in neonatal Escherichia coli sepsis and ampicillin resistance in the era of intrapartum antibiotic prophylaxis. Pediatrics. 2008;121:689–96.CrossRefGoogle Scholar
  14. 14.
    Heideking M, Lander F, Hufnagel M, et al. Antibiotic susceptibility profiles of neonatal invasive isolates of Escherichia coli from a 2-year nationwide surveillance study in Germany, 2009-10. Eur J Clin Microbiol Infect Dis. 2013;32:1221–3.CrossRefPubMedGoogle Scholar
  15. 15.
    Downie L, Armiento R, Subhi R, Kelly J, Clifford V, Duke T. Community-acquired neonatal and infant sepsis in developing countries: efficacy of WHO’s currently recommended antibiotics – systematic review and meta-analysis. Arch Dis Child. 2013;98:146–54.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Greenhow TL, Cantey JB. The disputed champion: ampicillin and gentamicin for febrile young infants. Hosp Pediatr. 2017; Available online Jul 20 2017.Google Scholar
  17. 17.
    Johnson SJ, Ernst EJ, Moores KG. Is double coverage of gram-negative organisms necessary? Am J Heatlh Syst Pharm. 2011;68:119–24.CrossRefGoogle Scholar
  18. 18.
    Stockmann C, Spigarelli MG, Campbell SC, et al. Considerations in the pharmacologic treatment and prevention of neonatal sepsis. Pediatr Drugs. 2014;16:67–81.CrossRefGoogle Scholar
  19. 19.
    Mohan P, Brocklehurst P. Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaenia. Cochrane Database Syst Rev. 2003;4:CD003956.Google Scholar
  20. 20.
    INIS Collaborative Group, Brocklehurst P, Farrell B, et al. Treatment of neonatal sepsis with intravenous immune globulin. N Engl J Med. 2011;265:1201–11.Google Scholar
  21. 21.
    Pammi M, Haque KN. Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev. 2015;3:CD004205.Google Scholar
  22. 22.
    Carr R, Brocklehurst P, Dore CJ, Modi N. Granulocyte-macrophage colony stimulating factor administered as prophylaxis for reduction of sepsis in extremely preterm, small for gestational age neonates (the PROGRAMS trial): a single-blind, multicenter, randomised controlled trial. Lancet. 2009;373:226–33.CrossRefPubMedGoogle Scholar
  23. 23.
    Clifford V, Garland SM, Grimwood K. Prevention of neonatal group B streptococcus disease in the 21st century. J Paediatr Child Health. 2012;48:808–15.CrossRefPubMedGoogle Scholar
  24. 24.
    Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P. Missed opportunities for preventing group B streptococcus infection. Arch Dis Child Fetal Neonatal Ed. 2010;95:F72–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Van Dyke MK, Phares CR, Lynfield R, et al. Evaluation of universal antenatal screening for group B streptococcus. N Engl J Med. 2009;360:2626–36.CrossRefPubMedGoogle Scholar
  26. 26.
    Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann. 1993;22:711–4.CrossRefPubMedGoogle Scholar
  27. 27.
    Vekemans J, Moorthy V, Friede M, et al. Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 2018; Available online Feb 2 2018.Google Scholar
  28. 28.
    Shapiro-Mendoza CK, Barfield WD, Henderson Z, et al. CDC grand rounds: public health strategies to prevent preterm birth. MMWR Morb Mortal Wkly Rep. 2016;65:826–30.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of PediatricsUniversity of Texas Health Science Center San AntonioSan AntonioUSA

Personalised recommendations